ProteinMD for Clinicians
Protein targets your patients can actually follow.
ProteinMD turns guideline-based targets for CKD, PKU and other conditions into daily food choices and gives you a dashboard to see how patients are doing between visits.
Provider dashboard
Between-visit visibility, without the busywork
Patient list
De-identified IDs, condition, target, last log, adherence and status. Filter by condition, adherence or alerts.
Individual trends
7-day protein vs. target, phosphorus/potassium (CKD) or phenylalanine (PKU), recent entries.
Smart alerts
Not logging for 7 days, consistently over target, high-phosphorus foods, surfaced automatically.
Report review
Patient-generated PDF/CSV reports ready for the visit, with provider notes.
Secure messaging
Adjust targets and send guidance to patients inside the app.
Role-based access
Nephrologist, metabolic dietitian, clinic admin and read-only roles with audit logs.
Interoperability
Built to fit your EHR workflow
ProteinMD is designed around HL7 FHIR R4 and SMART on FHIR, so clinicians can launch it from the EHR and patient summaries can flow back as structured observations.
- Launch: Clinician opens ProteinMD from the EHR via SMART on FHIR.
- Set target: Protein or Phe target is set for the patient.
- Track: Patient logs meals in the app.
- Return: Summaries post back to the chart as FHIR Observations.
Security & compliance
- Architected for HIPAA: encryption in transit and at rest, BAAs with infrastructure providers
- Role-based access control and audit logging
- Clinical content sourced from authoritative guidelines (e.g. KDOQI 2020) and reviewed by an advisory board of RDs and MDs
- Positioned as clinical decision support: clinicians set and approve targets
Compliance features are in development and will be verified before clinical launch.
Evidence
Clinical pilot study
Usability and acceptability of ProteinMD Clinical Mode for patients with chronic kidney disease and phenylketonuria: a mixed-methods pilot.
Per participant
Single-arm, mixed-methods design.
CKD stage 3–4
Adults, non-dialysis, eGFR 15–59.
Adults with PKU
Recruited with metabolic clinics.
Primary outcome
Usability & acceptability; knowledge, confidence and clinician satisfaction secondary.
Protocol pending IRB approval. Clinics interested in participating are welcome to contact us.
Partner with us